In our study, the mean age of male carriers was 28 years, and only one male carrier (6.7%) among the fifteen unaffected male BRCA1/2 carriers was above 40, which is the age recommended for prostate cancer surveillance in the guidelines. The gene discussed is BRCA1; the disease is prostate cancer.